Conference Call with IOL Chemicals and Pharmaceuticals Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
Highlights: IOL Chemicals and Pharmaceuticals Limited a leading manufacturer of pharmaceutical (APis) and specialty chemicals today posted its financial results for the quarter and half year ending 30th September 2021. The Company on QoQ basis recorded 5% growth in total income, however the EBITDA has been declined by about 53% on QoQ basis. Dr Sanjay Chaturvedi, Chief Executive Officer said ''During the quarter ended September 2021, the Company's performance has been muted presently due to contraction in flagship API demand and volatility in raw material prices of Chemical products. He further stated that revenue from new products in pharma API has been getting positive response." Result PDF